Pharma’s Social Media Working Group
This article reviews the Who, What, and Why of Pharma's Social Media Working Group (SMWG) based on a conversation with Mark Gaydos, Senior Director, U.S. Regulatory Affairs Marketed Products at sanofi-aventis, and Cynthia Phillips, Sr Dir Labeling and Promotional Compliance at Millennium Pharmaceuticals. Also covered is an analysis of comments the SMWG submitted to the FDA on how pharmaceutical companies should handle off-label and adverse event posts made on social media sites owned or sponsored by them.
Use of Behavioral Targeting by Pharma Marketers
This article summarizes the results of a survey designed to answer the questions: Should the pharmaceutical industry adopt similar self-regulatory principles that were established by media and marketing trade associations to protect consumer privacy when employing behavioral targeting, Should pharma marketers use behavioral targeting at all?, If they do use it, when is it appropriate?
PREVIEW Pharma Marketing News Vol. 9, #2
Welcome to the Preview of the February 2010 issue of Pharma Marketing News.
Pharma Marketing News Vol. 9, #2: February 2010
Welcome to the FEBRUARY 2010 issue of Pharma Marketing News.
Pharma Marketing News Vol. 9, #2: February 2010
Welcome to the FEBRUARY 2010 issue of Pharma Marketing News.
Use of Twitter for Patient Support
Twitter has often been hyped as a great way to support customers. The customers of pharma are physicians and patients. But pharma Twitter accounts offer very little in terms of patient support. This article summarizes a survey that asked respondents to evaluate several ways in which Twitter could be used to improve patient support.
Building the “New” Pharma Physician Marketing Model
This article reviews MedTera's HC Professional
Predicting the Future of the Drug Industry
This article reviews the results of the 'Predicting the Future of the Drug Industry: 2010 & Beyond!' survey and provides background on future trends.
Corporate Reputation in the New Media World
In an online webinar entitled 'Reputation Strategies That Drive Results: Turning Your Good Name into Good Business' Kantar Health explored the value of corporate reputation and corporate social responsibility from a traditional channel and digital media perspective and also from the view of understanding how this impacts the relationship between pharmaceutical and Key Opinion Leaders. This article summarizes the presentations made at that webinar.
Pharma Marketing News Vol. 9, #1: January 2010
Welcome to the JANUARY 2010 issue of Pharma Marketing News.
